Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Egalet Corp (NASDAQ:EGLT)

10.40
Delayed Data
As of Aug 27
 +0.05 / +0.48%
Today’s Change
3.81
Today|||52-Week Range
17.03
+82.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$259.4M

Company Description

Egalet Corp. pharmaceutical company which develops, manufactures and commercializes innovative medicines for patients with acute and chronic pain while helping to protect physicians, families and communities from the burden of prescription abuse. The company is developing a pipeline of clinical stage opioid based product candidates that are specifically designed to deter abuse by physical and chemical manipulation. Its products portfolio include SPRIX nasal spray and OXAYDO tablets which are used to treat pain. The company was founded in August 2013 and is headquartered in Malvern, PA.

Contact Information

Egalet Corp.
460 East Swedesford Road
Wayne Pennsylvania 19087
P:(610) 833-4200
Investor Relations:

Employees

Shareholders

Other institutional5.01%
Individual stakeholders31.92%
Mutual fund holders14.67%

Top Executives

Robert Samuel RadiePresident, Chief Executive Officer & Director
Stanley J. MusialChief Financial Officer & Secretary
Karsten LindhardtVice President-Research & Development
Jeffrey M. DaynoChief Medical Officer
Mark StrobeckChief Business Officer